Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that a loading dose of 20 mg/kg and a maintenance dose of 5 mg/kg of
Levetiracetam is going to be safe and effective in the treatment of seizures in neonates.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Richard H. Haas
Collaborators:
Pediatric Pharmacology Research Units Network Thrasher Research Fund